Anupam Rasayan has signed Letter of Intent (LoI) worth revenue of $265 Million (Rs 2,186 crore) for next 5 years with one of the leading Japanese Speciality Chemical company to supply new age patented life science active ingredient. The product will be in validation phase for the next eighteen months and upon the successful validation, the supply will commence from CY2025. This product will be manufactured in our existing multipurpose manufacturing facilities.
Anupam Rasayan India (ARIL) is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India.
